Your session is about to expire
← Back to Search
Tegaderm vs. Transpore Eye Tape for Eyelid Redness
Study Summary
This trial will compare the rate of erythema, or redness, on the eyelids after anesthesia when a TegadermTM patch is used compared to a Transpore® patch. The hypothesis is that there will be no difference in the rate of erythema between the two groups.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I will have surgery lying on my stomach.I have had surgery on my head, brain, neck, teeth, mouth, eyes, or face.I have redness or injury on my eyelid.I am under 18 years old.I am scheduled for surgery that requires anesthesia.I am 18 years old or older.You have piercings on your eyelids.
- Group 1: Tegaderm Left
- Group 2: Transpore Right
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does Tegaderm Eye Tape present any potential hazards for users?
"Considering that Tegaderm Eye Tape is approved, and thus extensively tested for safety, our analysts rated it with a score of 3."
What is the upper limit for individuals enrolled in this investigation?
"Affirmative. The clinicaltrials.gov registry indicates that this trial, which was first posted on June 11th 2021, is actively recruiting participants from a single site. A total of 165 volunteers are required to complete the study."
Are there still open slots to participate in this experiment?
"Affirmative. As per the information found on clinicaltrials.gov, this trial is actively seeking participants and has been since it was published on June 11th 2021. The most recent update to the study details was made April 26th 2022, which outlines a recruitment target of 165 patients from one medical centre."
Share this study with friends
Copy Link
Messenger